Gujarat Themis Biosyn Limited (BOM:506879)
404.10
-29.40 (-6.78%)
At close: May 29, 2026
Gujarat Themis Biosyn Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 60.88 | 116.94 | 64.69 | 60.55 | 2.61 |
Short-Term Investments | - | - | 76.58 | 28.48 | 215.79 |
Cash & Short-Term Investments | 60.88 | 116.94 | 141.28 | 89.03 | 218.4 |
Cash Growth | -47.94% | -17.23% | 58.69% | -59.24% | -45.68% |
Accounts Receivable | 609.17 | 312.38 | 270.26 | 179.05 | 251.18 |
Other Receivables | - | 2.1 | 5.67 | 8.97 | 14.5 |
Receivables | 609.23 | 314.51 | 275.95 | 363.03 | 440.88 |
Inventory | 154.23 | 54.81 | 38.4 | 146.19 | 116.1 |
Prepaid Expenses | - | 1.58 | 3.59 | 4.7 | 3.12 |
Restricted Cash | - | 3.33 | 7.66 | 0.31 | 0.31 |
Other Current Assets | 63.51 | 28.56 | 8.76 | 14.05 | 5.07 |
Total Current Assets | 887.84 | 519.73 | 475.62 | 617.3 | 783.86 |
Property, Plant & Equipment | 4,100 | 2,255 | 1,292 | 532.56 | 321.29 |
Long-Term Investments | - | 9.4 | 309.4 | 396.99 | 89.86 |
Other Intangible Assets | 0.96 | 1.59 | - | - | - |
Other Long-Term Assets | 37.82 | 219.53 | 126.21 | 116.44 | 29.99 |
Total Assets | 5,034 | 3,013 | 2,211 | 1,663 | 1,225 |
Accounts Payable | 366.54 | 146.5 | 99.08 | 95.45 | 66.18 |
Accrued Expenses | 3.11 | 32.9 | 36.37 | 43.86 | 64.53 |
Current Portion of Long-Term Debt | 318.02 | 2.54 | - | - | - |
Current Portion of Leases | 12.95 | 5.8 | 15.44 | 4.19 | 7.5 |
Current Income Taxes Payable | 1.38 | - | - | 5.28 | 17.1 |
Other Current Liabilities | 89.48 | 17.86 | 10.7 | 4.01 | 16.26 |
Total Current Liabilities | 791.48 | 205.6 | 161.59 | 152.78 | 171.58 |
Long-Term Debt | 1,281 | 296.36 | - | - | - |
Long-Term Leases | 6.51 | - | 12.25 | - | 4.19 |
Pension & Post-Retirement Benefits | - | 3.89 | 4.01 | 3.41 | 3.62 |
Long-Term Deferred Tax Liabilities | 65.86 | 19.62 | 16.64 | 13 | 10.24 |
Other Long-Term Liabilities | 12.09 | 3.84 | 2.88 | 2.63 | 2.17 |
Total Liabilities | 2,157 | 529.31 | 197.37 | 171.82 | 191.79 |
Common Stock | 108.97 | 108.97 | 72.64 | 72.64 | 72.64 |
Additional Paid-In Capital | - | - | 21.64 | 21.64 | 21.64 |
Retained Earnings | - | 2,373 | 1,918 | 1,396 | 937.36 |
Comprehensive Income & Other | 2,769 | 1.57 | 1.57 | 1.57 | 1.57 |
Shareholders' Equity | 2,878 | 2,484 | 2,014 | 1,491 | 1,033 |
Total Liabilities & Equity | 5,034 | 3,013 | 2,211 | 1,663 | 1,225 |
Total Debt | 1,618 | 304.7 | 27.68 | 4.19 | 11.69 |
Net Cash (Debt) | -1,557 | -187.76 | 113.59 | 84.84 | 206.7 |
Net Cash Growth | - | - | 33.89% | -58.96% | -41.56% |
Net Cash Per Share | -14.28 | -1.72 | 1.04 | 0.78 | 1.90 |
Filing Date Shares Outstanding | 108.97 | 108.97 | 108.97 | 108.97 | 108.97 |
Total Common Shares Outstanding | 108.97 | 108.97 | 108.97 | 108.97 | 108.97 |
Working Capital | 96.36 | 314.13 | 314.03 | 464.51 | 612.29 |
Book Value Per Share | 26.41 | 22.79 | 18.48 | 13.69 | 9.48 |
Tangible Book Value | 2,877 | 2,482 | 2,014 | 1,491 | 1,033 |
Tangible Book Value Per Share | 26.40 | 22.78 | 18.48 | 13.69 | 9.48 |
Land | - | 0.7 | 0.7 | 0.7 | 0.7 |
Buildings | - | 105.29 | 103.41 | 101.88 | 15.56 |
Machinery | - | 443.48 | 351.43 | 315.31 | 243.55 |
Construction In Progress | - | 1,844 | 912.24 | 205.94 | 126.98 |
Leasehold Improvements | - | 16.86 | 16.86 | - | - |